Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Individuals who reduce or stop use of opioid medications are at risk for developing
hyperalgesia, which is an increased sensitivity to pain. This study will compare the
effectiveness of dextromethorphan, gabapentin, and oxycodone at reducing hyperalgesia in
individuals addicted to opioids who are concurrently receiving methadone treatment.